Retatrutide
Triple agonist peptide (GLP-1/GIP/Glucagon) investigated for metabolic research. 10mg lyophilized powder, 99%+ purity.
Specifications
| Size | 10mg, 30mg, 60mg, 5mg, 15mg, 20mg |
| SKU | NP-RET-10 |
Description
Research Overview
Retatrutide (LY3437943) is a novel triple-acting agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. This multi-receptor approach has generated significant research interest in metabolic studies.
Specifications
- Quantity: 10mg per vial
- Form: Lyophilized powder
- Purity: ≥99% (HPLC verified)
- Storage: -20°C, protect from light
For laboratory and research use only. Not for human consumption. This product is not a drug, food, or cosmetic and should not be used as a substitute for medical advice or treatment.
All products are sold strictly for in-vitro research and laboratory use only. Not for human consumption. By purchasing, you agree to our research policy and confirm you are a qualified researcher.
Test Results — Certificate of Analysis
Independent third-party testing by Janoshik Analytical. Each COA is verifiable at janoshik.com/verify.
